Find Federal Grants
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
National Institutes of Health · PAR-24-043
BRAIN Initiative Connectivity across Scales Data Coordinating Center (BRAIN CONNECTS DCC) (U24 Clinical Trial Not Allowed)
National Institutes of Health · RFA-NS-24-028
RFI: Growing Carbon Management Education Capacity at Minority Serving Institutions (MSI) through the Office of Fossil Energy and Carbon Management (FECM) University Training and Research (UTR) Program
National Energy Technology Laboratory · DE-FOA-0003216
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
National Institutes of Health · PAR-24-063
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
National Institutes of Health · PAR-23-313
Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)
National Institutes of Health · PAR-24-039
Short Courses in Social Determinants of Health for Research Education in Nursing Research (R25 Independent Clinical Trial Not Allowed)
National Institutes of Health · RFA-NR-24-002
Advancing Technologies to Improve Delivery of Pharmacological, Gene Editing, and other Cargoes for HIV and SUD Mechanistic or Therapeutic Research (R01 Clinical Trial Optional)
National Institutes of Health · RFA-DA-25-022
Psychedelics Treatment Research in Substance Use Disorder (UG3/UH3 Clinical Trials Optional)
National Institutes of Health · RFA-DA-25-058
Fiscal Year (FY) 2024 AmeriCorps Seniors Senior Companion Program (SCP) Replacement and Expansion Opportunity
AmeriCorps · AC-11-02-23
Fiscal Year (FY 2024 AmeriCorps Seniors Foster Grandparents (FGP) Replacement and Expansion Opportunity Program
AmeriCorps · AC-11-01-23
HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
National Institutes of Health · RFA-NS-24-019
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
National Institutes of Health · PAR-23-314
Bureau of European and Eurasian Affairs · TR-NOFO-FY24-01
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
National Institutes of Health · PAR-23-295
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
National Institutes of Health · PAR-23-294
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
National Institutes of Health · PAR-23-293
Effect of HIV and Substance Use Comorbidity on the Placenta and Maternal Outcomes (R01 Clinical Trial Optional)
National Institutes of Health · RFA-DA-25-021
National Aeronautics and Space Administration · NNH24ZHA001C
Malawi USAID-Lilongwe · 72061223RFA00006